Please turn JavaScript on
header-image

Sydney Health Law

Want to know the latest news and articles posted on Sydney Health Law?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: Sydney Health Law – A blog on health governance, law, and ethics, by health law experts at Sydney Law School

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.14 / day

Message History

Extracellular vesicles are generating excitement as tools for regenerative medicine and drug delivery — but no EV-based therapeutic has received market approval anywhere in the world. In a new Perspective article, we argue the barriers are not solely technical. They are also regulatory.

Read full story
A recent post reviewed the tobacco control innovations introduced into Australia through the Public Health (Tobacco and Other Products) Act 2023 (Cth). New Zealand was legislating world-leading innovations of its own around the same time, although their purpose and design contrast sharply with tobacco control measures in Australia. If Australia’s legislation is best seen as [...

Read full story
Thursday 11 December Time: 6-7.30pm (Refreshments to follow lecture)Venue: Law Lounge, Level 1, New Law Building Annexe (F10A)Eastern Avenue, University of Sydney, Camperdown campus Register for this free public lecture here In this lecture, Emeritus Professor Terry Carney explores the harm and injustices experienced by vulnerable Australians due to social service...

Read full story
This post was written by Neil Francey, Research Affiliate, Sydney Health Law In an article in The Weekend Australian (13-14 September 2025), Associate Editor Eric Johnston argues that there should be a rethink of tobacco customs and excise duty, due to the scale of illicit trade in tobacco. Johnston’s piece was prompted by burnt-out tobacco […]

Read full story
While a new Melbourne trial finds psilocybin-assisted therapy beneficial for the mental health of terminally ill patients, Australia’s broader experiment with medical psychedelics faces challenges. Our analysis raises concerns over a patchwork of regulations, unlawful promotion, and the potential for patient harm, and urging improvements to the authorised prescriber scheme.

Read full story